{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390855201298938112.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1248/bpb.b21-00954"}},{"identifier":{"@type":"PMID","@value":"35650100"}},{"identifier":{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/bpb/45/6/45_b21-00954/_pdf"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2023225775"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"en","@value":"Association of Aggression and Antiepileptic Drugs: Analysis Using the Japanese Adverse Drug Event Report (JADER) Database"}],"dc:language":"en","description":[{"type":"abstract","notation":[{"@language":"en","@value":"<p>Aggression is the most common adverse effect of antiepileptic drugs (AEDs). This study aimed to investigate the association of aggression with AED use. The reporting odds ratio (ROR) from adverse event reports, submitted to the Japanese Adverse Drug Event Report database between 2004 and 2020, was used to calculate and investigate the association between AEDs and aggression. We also analyzed the association of aggression with the combined use of AEDs and the relationship between AED-associated aggression and patient characteristics. A total of 433 patients developed aggression. Significant aggression signals were detected for perampanel (crude ROR: 325.04, 95% confidence interval (CI): 118.48–752.58, <i>p</i> < 0.01), levetiracetam (crude ROR: 17.14, 95% CI: 10.33–26.90, <i>p</i> < 0.01), lacosamide (crude ROR: 16.90, 95% CI: 2.02–62.51, <i>p</i> < 0.01), lamotrigine (crude ROR: 15.98, 95% CI: 9.99–24.39, <i>p</i> < 0.01), valproate (crude ROR: 6.68, 95% CI: 4.27–10.02, <i>p</i> < 0.01), and carbamazepine (crude ROR: 2.47, 95% CI: 1.17–4.59, <i>p</i> < 0.01). The combined therapy with perampanel and levetiracetam had a significant aggression signal (adjusted ROR: 25.90, 95% CI: 1.14–59.10, <i>p</i> < 0.01). In addition, we found that aggression frequently occurred in patients <60 year (adjusted ROR: 2.88, 95% CI: 1.49–5.56, <i>p</i> < 0.01) treated with levetiracetam. These results may be useful for minimizing the risk of aggression during the treatment of AEDs.</p>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410855201298938115","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Ishida Tomoaki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Pharmacy, Kochi Medical School Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938240","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Kawada Kei"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Graduate School of Integrated Arts and Sciences, Kochi University"},{"@language":"en","@value":"Department of Pharmacy, Kochi Medical School Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938117","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Jobu Kohei"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Pharmacy, Kochi Medical School Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938113","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Ohta Tsuyoshi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Neurosurgery, National Cerebral and Cardiovascular Center Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938242","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Fukuda Hitoshi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Neurosurgery, Kochi Medical School, Kochi University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938114","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Morisawa Shumpei"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Graduate School of Integrated Arts and Sciences, Kochi University"},{"@language":"en","@value":"Department of Pharmacy, Kochi Medical School Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938241","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Kawazoe Tetsushi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Graduate School of Integrated Arts and Sciences, Kochi University"},{"@language":"en","@value":"Department of Pharmacy, Kochi Medical School Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938116","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Miyamura Mitsuhiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Graduate School of Integrated Arts and Sciences, Kochi University"},{"@language":"en","@value":"Department of Pharmacy, Kochi Medical School Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855201298938112","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Tamura Naohisa"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Graduate School of Integrated Arts and Sciences, Kochi University"},{"@language":"en","@value":"Department of Pharmacy, Kochi Medical School Hospital"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09186158"},{"@type":"EISSN","@value":"13475215"}],"prism:publicationName":[{"@language":"ja","@value":"Ｂｉｏｌｏｇｉｃａｌ　＆　Ｐｈａｒｍａｃｅｕｔｉｃａｌ　Ｂｕｌｌｅｔｉｎ"},{"@language":"en","@value":"Biological and Pharmaceutical Bulletin"},{"@language":"en","@value":"Biological & Pharmaceutical Bulletin"},{"@language":"en","@value":"Biol. Pharm. Bull."},{"@language":"ja","@value":"Ｂｉｏｌ．　Ｐｈａｒｍ．　Ｂｕｌｌ．"}],"dc:publisher":[{"@language":"en","@value":"The Pharmaceutical Society of Japan"},{"@language":"ja","@value":"公益社団法人 日本薬学会"}],"prism:publicationDate":"2022-06-01","prism:volume":"45","prism:number":"6","prism:startingPage":"720","prism:endingPage":"723"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://www.jstage.jst.go.jp/article/bpb/45/6/45_b21-00954/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2023225775"}],"availableAt":"2022-06-01","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=aggression","dc:title":"aggression"},{"@id":"https://cir.nii.ac.jp/all?q=antiepileptic%20drug","dc:title":"antiepileptic drug"},{"@id":"https://cir.nii.ac.jp/all?q=perampanel","dc:title":"perampanel"},{"@id":"https://cir.nii.ac.jp/all?q=levetiracetam","dc:title":"levetiracetam"},{"@id":"https://cir.nii.ac.jp/all?q=Japanese%20Adverse%20Drug%20Event%20Report%20database","dc:title":"Japanese Adverse Drug Event Report database"},{"@id":"https://cir.nii.ac.jp/all?q=aggression","dc:title":"aggression"},{"@id":"https://cir.nii.ac.jp/all?q=antiepileptic%20drug","dc:title":"antiepileptic drug"},{"@id":"https://cir.nii.ac.jp/all?q=perampanel","dc:title":"perampanel"},{"@id":"https://cir.nii.ac.jp/all?q=levetiracetam","dc:title":"levetiracetam"},{"@id":"https://cir.nii.ac.jp/all?q=Japanese%20Adverse%20Drug%20Event%20Report%20database","dc:title":"Japanese Adverse Drug Event Report database"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360013171002053248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171199459840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Conceptual Framework of Frailty: A Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013172148310144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016866626422400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of age and sex on brain glutamate and other metabolites"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710788330368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619597256704","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Adverse antiepileptic drug effects"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298343103373696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Benefit of combination therapy in epilepsy: A review of the preclinical evidence with levetiracetam"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298343120454656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095070533888","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Adverse effects of antiepileptic drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095770064128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576120681905536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579817073217920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Assessing the unmet treatment need in partial‐onset epilepsy: Looking beyond seizure control"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579818015040256","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Levetiracetam"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994611767936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418599081984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Early Identification of Refractory Epilepsy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895054662144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The reporting odds ratio and its advantages over the proportional reporting ratio"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369991945984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Causes of Epilepsy: Contributions of the Rochester Epidemiology Project"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844696683264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845857317760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320331226752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Synaptic Vesicle Protein 2 Enhances Release Probability at Quiescent Synapses"}]},{"@id":"https://cir.nii.ac.jp/crid/1363946394939639808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679609562496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database"}]},{"@id":"https://cir.nii.ac.jp/crid/1390293268648648064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Long-Term Administration of Q808 on Hippocampal Transcriptome in Healthy Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390848647560479872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Risk Factors for Pseudoaldosteronism with Yokukansan Use: Analysis Using the Japanese Adverse Drug Report (JADER) Database"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2009359956"},{"@type":"CROSSREF","@value":"10.1248/bpb.b21-00954"},{"@type":"PUBMED","@value":"35650100"},{"@type":"OPENAIRE","@value":"doi_dedup___::7e38035ef96a98ecd0a55604b7e37455"},{"@type":"CROSSREF","@value":"10.1248/cpb.c22-00357_references_DOI_XDSeWCTP1URrBT3lfXjdJLrvXOF"}]}